Article metrics

Download PDFPDF

Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial

 

Online download statistics by month:

Online download statistics by month: April 2019 to August 2020

AbstractFullPdf
Apr 201913413633
May 201916531683649
Jun 201911171087321
Jul 2019540509241
Aug 2019343303138
Sep 2019252200103
Oct 2019311265110
Nov 201930526270
Dec 201923519967
Jan 202015813656
Feb 202012610341
Mar 202012711261
Apr 202013710660
May 2020121106127
Jun 2020917953
Jul 2020877938
Aug 2020878532
Total582454502200